Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? PJ Serrano-Castro, G Estivill-Torrús, P Cabezudo-García, ... Neurología (English Edition) 35 (4), 245-251, 2020 | 192 | 2020 |
Incidence and case fatality rate of COVID-19 in patients with active epilepsy P Cabezudo-García, NL Ciano-Petersen, N Mena-Vázquez, G Pons-Pons, ... Neurology 95 (10), e1417-e1425, 2020 | 111 | 2020 |
Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas:¿ una pandemia demorada? PJ Serrano-Castro, G Estivill-Torrús, P Cabezudo-García, ... Neurología 35 (4), 245-251, 2020 | 75 | 2020 |
Response to immunotherapy in anti‐IgLON5 disease: a systematic review P Cabezudo‐García, N Mena‐Vázquez, G Estivill Torrús, ... Acta neurologica Scandinavica 141 (4), 263-270, 2020 | 65 | 2020 |
Guía clínica para el diagnóstico y seguimiento de la distrofia miotónica tipo 1, DM1 o enfermedad de Steinert GG Gutiérrez, J Díaz-Manera, M Almendrote, S Azriel, JE Bárcena, ... Medicina Clínica 153 (2), 82. e1-82. e17, 2019 | 41 | 2019 |
Efficacy of antiepileptic drugs in autoimmune epilepsy: a systematic review P Cabezudo-García, N Mena-Vázquez, M Villagrán-García, ... Seizure 59, 72-76, 2018 | 41 | 2018 |
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease GG Gutiérrez, J Díaz-Manera, M Almendrote, S Azriel, JE Bárcena, ... Medicina Clínica (English Edition) 153 (2), 82. e1-82. e17, 2019 | 39 | 2019 |
The cognitive and psychiatric subacute impairment in severe Covid-19 PJ Serrano-Castro, FJ Garzón-Maldonado, I Casado-Naranjo, ... Scientific reports 12 (1), 3563, 2022 | 35 | 2022 |
Current status of biomarkers in anti-N-Methyl-D-Aspartate receptor encephalitis NL Ciano-Petersen, P Cabezudo-García, S Muñiz-Castrillo, J Honnorat, ... International Journal of Molecular Sciences 22 (23), 13127, 2021 | 26 | 2021 |
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: outcomes from an expanded access program V Villanueva, D Santos‐Carrasco, P Cabezudo‐García, A Gómez‐Ibáñez, ... Epilepsia open 8 (3), 918-929, 2023 | 25 | 2023 |
COVID-19 prevalence and mortality in people with epilepsy: a nation-wide multicenter study A Sanchez-Larsen, E Conde-Blanco, A Viloria-Alebesque, CSV Buendía, ... Epilepsy & Behavior 125, 108379, 2021 | 22 | 2021 |
Case fatality of COVID-19 in patients with neurodegenerative dementia JA Reyes-Bueno, N Mena-Vázquez, T Ojea-Ortega, ... Neurología (English Edition) 35 (9), 639-645, 2020 | 20 | 2020 |
Incidence and case fatality rate of COVID‐19 in patients with inflammatory articular diseases N Mena Vázquez, S Manrique‐Arija, P Cabezudo‐García, ... International Journal of Clinical Practice 75 (4), e13707, 2021 | 17 | 2021 |
Immune mechanism of epileptogenesis and related therapeutic strategies MJ Aguilar-Castillo, P Cabezudo-García, NL Ciano-Petersen, ... Biomedicines 10 (3), 716, 2022 | 16 | 2022 |
Prevalence of neural autoantibodies in epilepsy of unknown etiology: systematic review and meta-analysis P Cabezudo-García, N Mena-Vázquez, NL Ciano-Petersen, ... Brain Sciences 11 (3), 392, 2021 | 12 | 2021 |
Functional outcomes of patients with NORSE and FIRES treated with immunotherapy: a systematic review P Cabezudo-García, N Mena-Vázquez, NL Ciano-Petersen, ... Neurología (English Edition), 2022 | 9 | 2022 |
Neuroplasticity and epilepsy surgery in brain eloquent areas: case report PJ Serrano-Castro, B Ros-López, VE Fernández-Sánchez, ... Frontiers in neurology 11, 698, 2020 | 8 | 2020 |
FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) in a patient with Crohn's disease on anti-TNF treatment P Cabezudo-García, MV Denis, NL Ciano-Petersen, ... Neurologia 37 (4), 304-306, 2022 | 7 | 2022 |
Efficacy and safety of Rituximab in vasculitic neuropathy: a systematic review of the literature N Mena-Vázquez, P Cabezudo-García, CF Varela, S Manrique-Arija, ... Reumatología Clínica (English Edition) 15 (3), 173-178, 2019 | 7 | 2019 |
Análisis de letalidad por COVID-19 en pacientes con demencia neurodegenerativa JA Reyes-Bueno, N Mena-Vázquez, T Ojea-Ortega, ... Neurología 35 (9), 639-645, 2020 | 6 | 2020 |